The past 100 years have seen many remarkable advances against cancer, a disease known to mankind for thousands of years. The accomplishments of the last 30 years in particular, such as the development of monoclonal antibodies and other targeted therapies, the identification of cancer-associated genes, the introduction of computer-assisted imaging, and the decline in cancer deaths since the mid-1990s, have all built on knowledge gained in earlier decades.